Total thyroidectomy for medically refractory amiodarone-induced thyrotoxicosis
- PMID: 18982079
- PMCID: PMC2566909
- DOI: 10.1080/08998280.2008.11928432
Total thyroidectomy for medically refractory amiodarone-induced thyrotoxicosis
Abstract
Amiodarone is a class III antiarrhythmic drug widely used for both ventricular and supraventricular tachyarrhythmias. Due to its high iodine content and structural similarity to thyroxine, abnormalities in thyroid function are common in patients taking amiodarone, especially with long-term use. Both hypo- and hyperthyroidism have been associated with amiodarone, with the former far more common in the United States. We present a patient with medically refractory amiodarone-induced thyrotoxicosis after a 2-year history of amiodarone use, resulting in cardiac arrest and encephalopathy. The patient ultimately required total thyroidectomy for symptomatic control.
Figures
References
-
- Basaria S, Cooper D. Amiodarone and the thyroid. Am J Med. 2005;118(7):706–714. - PubMed
-
- Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, Pacchiarotti A, Aronin N, Macchia E, Haffajee C. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984;101(1):28–34. - PubMed
-
- Zipes DP, Libby PBRO, Braunwald E. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia: WB Saunders; 2005.
-
- Martino E, Bartalena L, Bogazzi F, Baverman LE. The effects of amiodarone on the thyroid. Endocr Rev. 2001;22(2):240–254. - PubMed
LinkOut - more resources
Full Text Sources